|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | B01D 15/20 | |
| B01D 15/38 | |||
| C07K 16/00 | |||
| C07K 1/22 |
| (11) | Number of the document | 2969098 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14713926.5 |
| Date of filing the European patent application | 2014-03-13 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2014/059755 |
| Date | 2014-03-13 |
| (87) | Number | WO 2014/141150 |
| Date | 2014-09-18 |
| (30) | Number | Date | Country code |
| 201361787309 P | 2013-03-15 | US |
| (72) |
GOKLEN, Kent E., US
SUDA, Eric J., US
UBIERA, Antonio Raul, US
|
| (73) |
GlaxoSmithKline Intellectual Property (No. 2) Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (54) | METHODS FOR PURIFYING ANTIBODIES |
| METHODS FOR PURIFYING ANTIBODIES |